RxDoctor Payments Data

Patrick Baquet, MD

Family Medicine · New Iberia, LANPI 1326078577

Payments from drug & device makers

$5,492in general payments, 2019–2025

Across 380 payments — averaging $14.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$472
  • Corium, LLC$446
  • Takeda Pharmaceuticals U.S.A., Inc.$369
  • Lilly USA, LLC$243
  • Pfizer$226
  • plus $2K from 44 others

What the payments were for

  • Food & beverage$5,44899%
  • Education$441%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,492 in reported general payments places this provider in the 80th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$83,632
Medicare patients
237
Services billed
1,797

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide113$112,200
XareltoRivaroxaban63$50,882
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$37,049
MounjaroTirzepatide23$28,080
JardianceEmpagliflozin34$26,879
TrulicityDulaglutide25$23,105
FarxigaDapagliflozin Propanediol30$16,631
EliquisApixaban14$14,048
JanuviaSitagliptin Phosphate16$12,801
LinzessLinaclotide17$8,897
MyrbetriqMirabegron13$8,352
JanumetSitagliptin Phos/Metformin Hcl14$7,580
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine194$6,047
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,730
Novolog FlexpenInsulin Aspart11$5,347

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$170$112,200113 claims
Lilly USA, LLCMounjaro, Trulicity$243$51,18548 claims
Johnson & JohnsonXarelto$66$50,88263 claims
GSKTrelegy Ellipta, Anoro Ellipta$65$42,77861 claims
Boehringer IngelheimJardiance$114$26,87934 claims
MerckJanuvia, Janumet$88$20,38130 claims
AstraZenecaFarxiga$472$16,63130 claims
PfizerEliquis$226$14,04814 claims
AbbVieLinzess$1,577$8,89717 claims
Astellas Pharma US IncMyrbetriq$78$8,35213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in New Iberia

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →